{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T01:16:59Z","timestamp":1648689419279},"reference-count":22,"publisher":"Japanese Urological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5980\/jpnjurol.105.79","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T22:05:27Z","timestamp":1438639527000},"page":"79-84","source":"Crossref","is-referenced-by-count":1,"title":["CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH ADRENOCORTICAL CARCINOMA"],"prefix":"10.5980","volume":"105","author":[{"given":"Noriyoshi","family":"Miura","sequence":"first","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uda","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutaka","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Asai","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomi","family":"Shirato","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Kikugawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Tanji","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Ehime University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fassnacht M, Wittekind C and Allolio B: Current TNM classification system for adrenocortical carcinoma. Pathologe, 31, 374-378, 2010.","DOI":"10.1007\/s00292-010-1306-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Zini L, Porpiglia F and Fassnacht M: Contemporary management of adrenocortical carcinoma. Eur. Urol., 60, 1055-1065, 2011.","DOI":"10.1016\/j.eururo.2011.07.062"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lebastchi AH, Kunstman JW and Carling T: Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art. J. Oncol., Epub 2012.","DOI":"10.1155\/2012\/234726"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Mendonca BB, Lucon AM, Menezes CAV, Saldanha LB, Latronico AC, Zerbini C, Madureira G, Domenice S, Alberqaria MA, Camargo MH, Halpern A, Liberman B, Amhold JP, Bloise W, Andriolo A, Nicolau W, Silvia F, Wroclaski E, Arap S and Wajchenberg BL: Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. J. Urol., 154, 2004-2009, 1995.","DOI":"10.1016\/S0022-5347(01)66673-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Ng L and Libertino JM: Adrenocortical carcinoma: diagnosis, evaluation and treatment. J. Urol., 169, 5-11, 2003.","DOI":"10.1016\/S0022-5347(05)64023-2"},{"key":"6","doi-asserted-by":"publisher","unstructured":"7) Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S and Allolio B: Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer, 115, 243-250, 2009.","DOI":"10.1002\/cncr.24030"},{"key":"7","doi-asserted-by":"publisher","unstructured":"8) Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E and Sturgeon C: Adrenocortical carcinoma in the United States. Cancer, 113, 3130-3136, 2008.","DOI":"10.1002\/cncr.23886"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Schulick RD and Brennan MF: Long term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann. Surg. Oncol., 6, 719-726, 1999.","DOI":"10.1007\/s10434-999-0719-7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Nishida S, Itoh N, Sasao T, Masumori N, Taguchi K and Tsukamoto T: Adrenocortical carcinoma: Retrospective study of 14 patients experienced at a single institution over 34 years. Int. J. Urol., 14, 581-584, 2007.","DOI":"10.1111\/j.1442-2042.2007.01792.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Ohwada S, Izumi M, Kawate S, Hamada K, Toya H, Togo N, Horiguchi J, Koibuchi Y, Takahashi T and Yamada M: Surgical outcome of stage III and IV adrenocortical carcinoma. Jpn J Clin Oncol, 37, 108-113, 2007.","DOI":"10.1093\/jjco\/hyl127"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Chiche L, Dousset B, Kieffer E and Chapuis Y: Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery, 139, 15-27, 2006.","DOI":"10.1016\/j.surg.2005.05.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, Berruti A and Terzolo M: Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur. Urol., 57, 873-878, 2010.","DOI":"10.1016\/j.eururo.2010.01.036"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Brix D, Allolio B, Fenske W, Agha A, Dralle H, Jurowich C, Langer P, Mussack T, Nies C, Riedmiller H, Spahn M, Weismann D, Hahner S and Fassnacht M: Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur. Urol., 58, 609-615, 2010.","DOI":"10.1016\/j.eururo.2010.06.024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Datrice NM, Langan RC, Ripley RT, Kemp CD, Steinberg SM, Wood BJ, Libutti SK, Fojo T, Schrump DS and Avital I: Operative management for recurrent and metastatic adrenocortical carcinoma. J. Surg. Oncol., 105, 709-713, 2012.","DOI":"10.1002\/jso.23015"},{"key":"15","doi-asserted-by":"publisher","unstructured":"16) Vassilopoulou-Sellin R, Guinee VF, Klein MJ, Taylor SH, Hess KR, Schultz PN and Samaan NA: Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer, 71, 3119-3123, 1993.","DOI":"10.1002\/1097-0142(19930515)71:10<3119::AID-CNCR2820711037>3.0.CO;2-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L and Berruti A: Adjuvant mitotane treatment for adrenocortical carcinoma. N. Engl. J. Med., 7, 2372-2380, 2007.","DOI":"10.1056\/NEJMoa063360"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) W\u00e4ngberg B, Khorram-Manesh A, Jansson S, Nilsson B, Nilsson O, Jakobsson CE, Lindstedt S, Od\u00e9n A and Ahlman H: The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Endocr. Rela.t Cancer, 18, 265-272, 2010.","DOI":"10.1677\/ERC-09-0190"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, Skogseid B, Allolio B and Terzolo M: Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. J. Clin. Oncol., 28, e401-402, 2010.","DOI":"10.1200\/JCO.2009.27.5958"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Haak HR, Hermans J, Van de Velde CJ, Lentjes EG, Goslings BM, Fleuren GJ and Krans HM: Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br. J. Cancer, 69, 947-951, 1994.","DOI":"10.1038\/bjc.1994.183"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Gonzalez RJ, Tamm EP, Ng C, Phan AT, Vassilopoulou-Sellin R, Perrier ND, Evans DB and Lee JE: Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery, 142, 867-875, 2007.","DOI":"10.1016\/j.surg.2007.09.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardi\u00e8re C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, M\u00fcller HH and Skogseid B; FIRM-ACT Study Group: Combination chemotherapy in advanced adrenocortical carcinoma. N. Engl. J. Med., 366, 2189-2197, 2012.","DOI":"10.1056\/NEJMoa1200966"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Naing A, Lorusso P and Fu S, et al: Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma. Br. J. Cancer., 108, 826-830, 2013.","DOI":"10.1038\/bjc.2013.46"}],"container-title":["The Japanese Journal of Urology"],"original-title":["\u526f\u814e\u76ae\u8cea\u764c7\u4f8b\u306e\u81e8\u5e8a\u75c5\u7406\u5b66\u7684\u7279\u5fb4\u3068\u4e88\u5f8c\u306e\u691c\u8a0e"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_79\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T01:19:51Z","timestamp":1567041591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_79\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.105.79","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}